Go Hirai

Prof. Go Hirai

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2009 in Chemistry & Biology
Verified
Journal Article
Closed access
IFIsao Fukuda
Isao Fukuda
AIAkihiro Ito
Akihiro Ito
GHGo Hirai
Go Hirai
SNShinichi Nishimura
Shinichi Nishimura
Hisashi KawasakiHisashi Kawasaki
Hisashi Kawasaki
MYMinoru Yoshida
Minoru Yoshida

1 October 2008 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
KHKeiko Hata
Keiko Hata
KKKoichi Koseki
Koichi Koseki
KYKazunori Yamaguchi
Kazunori Yamaguchi
SMSetsuko Moriya
Setsuko Moriya
YSYasuo Suzuki
Yasuo Suzuki
TMTaeko Miyagi
Taeko Miyagi
Oseltamivir (Tamiflu) and zanamivir (Relenza), two extensively used clinically effective anti-influenza drugs, are viral sialidase (also known as neuraminidase) inhibitors that prevent the release of progeny virions and thereby limit the spread of infection. Recently mortalities and neuropsychiatric events have been reported with the use of oseltamivir, especially in pediatric cases in Japan, suggesting that these drugs might also inhibit endogenous enzymes involved in sialic acid metabolism, including sialidase, sialyltransferase, and CMP-synthase, in addition to their inhibitory effects on the viral sialidase. The possible inhibition could account for some of the rare side effects of oseltamivir. However, there has been little direct evidence in regard to the sensitivities of animal sialidases to these drugs. Here, we examined whether these inhibitors might indeed affect the activities of human sialidases, which differ in primary structures and enzyme properties but possess tertiary structures similar to those of the viral enzymes. Using recombinant enzymes corresponding to the four human sialidases identified so far, we found that oseltamivir carboxylate scarcely affected the activities of any of the sialidases, even at 1 mM, while zanamivir significantly inhibited the human sialidases NEU3 and NEU2 in the micromolar range ( K i , 3.7 ± 0.48 and 12.9 ± 0.07 μM, respectively), providing a contrast to the low nanomolar concentrations at which these drugs block the activity of the viral sialidases.

23 November 2007 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
GHGo Hirai
Go Hirai
TWToru Watanabe
Toru Watanabe
KYKazunori Yamaguchi
Kazunori Yamaguchi
TMTaeko Miyagi
Taeko Miyagi
MSMikiko Sodeoka
Mikiko Sodeoka

24 February 2021 in Organic Letters
Verified
Journal Article
Closed access
DTDaiki Takeda
Daiki Takeda
MYMakoto Yoritate
Makoto Yoritate
HYHiroki Yasutomi
Hiroki Yasutomi
SCSuzuka Chiba
Suzuka Chiba
TMTakahiro Moriyama
Takahiro Moriyama
GHGo Hirai
Go Hirai

8 November 2016 in Scientific Reports
Verified
Journal Article
Open access
KYKosuke Yamamoto
Kosuke Yamamoto
TSTakashi Shimizu
Takashi Shimizu
KIKazunobu Igawa
Kazunobu Igawa
KTKatsuhiko Tomooka
Katsuhiko Tomooka
GHGo Hirai
Go Hirai
KUKazuteru Usui
Kazuteru Usui
A series of novel optically active [5]helicene-derived phosphine ligands (L1, with a 7,8-dihydro[5]helicene core structure- and L2, with a fully aromatic [5]helicene core structure) were synthesized. Despite their structural similarities, L1 and L2 exhibit particularly different characteristics in their use as chiral ligands. L1 was highly effective in the asymmetric allylation of indoles with 1,3-diphenylallyl acetate (up to 99% ee), and in the etherification of alcohols (up to 96% ee). In contrast, L2 was highly effective in the stereocontrol of helical chirality in Suzuki–Miyaura coupling (SMC) reaction (up to 99% ee). Density functional theory analysis was employed to propose a model that accounts for the origin of the enantioselectivity in these reactions.

13 June 2023 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
TMTaishi Miura
Taishi Miura
MYMakoto Yoritate
Makoto Yoritate
GHGo Hirai
Go Hirai
C-Glycoside analogs of naturally occurring glycoconjugates are useful tools for chemical biology studies, but their synthesis usually requires protection of the hydroxyl groups of the glycosyl donors.